DK402485D0 - Tumorterapeutiskum og fremgangsmaade til dets fremstilling - Google Patents

Tumorterapeutiskum og fremgangsmaade til dets fremstilling

Info

Publication number
DK402485D0
DK402485D0 DK402485A DK402485A DK402485D0 DK 402485 D0 DK402485 D0 DK 402485D0 DK 402485 A DK402485 A DK 402485A DK 402485 A DK402485 A DK 402485A DK 402485 D0 DK402485 D0 DK 402485D0
Authority
DK
Denmark
Prior art keywords
procedure
preparation
tumor therapeutic
monoclonal antibodies
antigens
Prior art date
Application number
DK402485A
Other languages
English (en)
Other versions
DK172253B1 (da
DK402485A (da
Inventor
Klaus Bosslet
Hans-Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK402485D0 publication Critical patent/DK402485D0/da
Publication of DK402485A publication Critical patent/DK402485A/da
Application granted granted Critical
Publication of DK172253B1 publication Critical patent/DK172253B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DK402485A 1984-09-06 1985-09-03 Tumorterapeutikum, fremgangsmåde til dets fremstilling samt anvendelse af humane tumorceller til fremstilling af et terapeutikum til behandling af tumorlidelser DK172253B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3432714 1984-09-06
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (3)

Publication Number Publication Date
DK402485D0 true DK402485D0 (da) 1985-09-03
DK402485A DK402485A (da) 1986-03-07
DK172253B1 DK172253B1 (da) 1998-02-09

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK402485A DK172253B1 (da) 1984-09-06 1985-09-03 Tumorterapeutikum, fremgangsmåde til dets fremstilling samt anvendelse af humane tumorceller til fremstilling af et terapeutikum til behandling af tumorlidelser

Country Status (13)

Country Link
EP (1) EP0173951B1 (da)
JP (1) JPS6168427A (da)
AT (1) ATE64531T1 (da)
CA (1) CA1277600C (da)
DE (2) DE3432714A1 (da)
DK (1) DK172253B1 (da)
ES (1) ES8704082A1 (da)
FI (1) FI88360C (da)
GR (1) GR852149B (da)
IE (1) IE58638B1 (da)
IL (1) IL76289A (da)
PT (1) PT81093B (da)
ZA (1) ZA856807B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
AU717937B2 (en) 1995-02-24 2000-04-06 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
JP5355839B2 (ja) 2001-10-23 2013-11-27 ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． Ｐｓｍａ抗体およびタンパク質マルチマー
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
ATE64531T1 (de) 1991-07-15
PT81093A (de) 1985-10-01
IE58638B1 (en) 1993-10-20
DK172253B1 (da) 1998-02-09
IL76289A (en) 1992-01-15
JPS6168427A (ja) 1986-04-08
GR852149B (da) 1986-01-03
EP0173951B1 (de) 1991-06-19
EP0173951A3 (en) 1988-06-08
FI88360B (fi) 1993-01-29
PT81093B (pt) 1988-07-01
DK402485A (da) 1986-03-07
FI853389L (fi) 1986-03-07
IL76289A0 (en) 1986-01-31
FI853389A0 (fi) 1985-09-04
CA1277600C (en) 1990-12-11
EP0173951A2 (de) 1986-03-12
FI88360C (fi) 1993-05-10
ZA856807B (en) 1986-04-30
DE3432714A1 (de) 1986-04-24
IE852191L (en) 1986-03-06
ES546701A0 (es) 1987-03-16
DE3583265D1 (de) 1991-07-25
ES8704082A1 (es) 1987-03-16

Similar Documents

Publication Publication Date Title
FI891984A7 (fi) Kineerinen vasta-aine, joka on spesifinen ihmisen kasvainantigeenille
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
EP0161606A3 (en) Drug, and methods of preparing and using it for treatment of tumors
NO884795D0 (no) Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
NO904368D0 (no) Kryssbundne antistoffer og fremgangsmaate for deres fremstilling.
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DK402485A (da) Tumorterapeutiskum og fremgangsmaade til dets fremstilling
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
NO853466L (no) Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
NO965395L (no) Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen
DK78183A (da) Antistoffer og antigener, der er nyttige til diagnose og behandling af cancer
EP0194851A3 (en) Human tumor therapy
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
DK107787D0 (da) Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
NO822801L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner
NO885088D0 (no) Omslagsmateriale, fremgangsmŸte for dets fremstilling og fremgangsmŸte til bruk av materialet.
IE873394L (en) Material for treatment of ammonia.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
IT8220082A0 (it) Composizione atta al trattamento terapeutico dei tumori.
ATE17190T1 (de) Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten.
DK354288D0 (da) Kimaert antistof med specificitet over for humant tumorantigen

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed